Summit Global Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.24M Buy
10,145
+3,350
+49% +$927K 0.12% 84
2026
Q1
$2.01M Sell
6,795
-3,513
-34% -$1.04M 0.12% 95
2025
Q4
$2.81M Sell
10,308
-2,752
-21% -$748K 0.17% 69
2025
Q3
$3.53M Sell
13,060
-2,408
-16% -$655K 0.21% 73
2025
Q2
$4.26M Buy
15,468
+13,631
+742% +$3.71M 0.25% 70
2025
Q1
$487K Sell
1,837
-210
-10% -$51.8K 0.04% 297
2024
Q4
$475K Sell
2,047
-10
-0.5% -$2.3K 0.03% 370
2024
Q3
$454K Buy
2,057
+787
+62% +$163K 0.03% 375
2024
Q2
$250K Sell
1,270
-26
-2% -$5.37K 0.02% 441
2024
Q1
$279K Buy
+1,296
New +$272K 0.02% 414

Other funds holding CME

Summit Global Investments's CME Position: Q2 2026 in Review

Summit Global Investments increased its CME Group (CME) stake by 49% in Q2 2026, buying an estimated $927K and bringing the position to 10,145 shares worth $2.24M. The position accounts for 0.12% of the portfolio, ranked #84.

Summit Global Investments first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.26M in Q2 2025. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Summit Global Investments held 10,145 shares of CME Group worth $2.24M as of Q2 2026.
  • Summit Global Investments bought 3,350 CME Group shares in Q2 2026, an estimated $927K.
  • CME Group made up 0.12% of Summit Global Investments's portfolio in Q2 2026, its #84 holding.
  • Summit Global Investments first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Summit Global Investments's CME Group position peaked at $4.26M in Q2 2025.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.